We are live on
!
Find out more
HRCM
Hood River Capital Management Portfolio holdings
AUM
$9.98B
1-Year Est. Return
145.42%
This Fund
S&P 500
This Quarter
Est. Return
+26.72%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$1.99B
AUM Growth
+$291M
(+17%)
Cap. Flow
-$58M
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
125
New
24
Increased
23
Reduced
53
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$30.3M |
| 2 |
Zumiez
ZUMZ
|
+$22M |
| 3 |
Merit Medical Systems
MMSI
|
+$21.9M |
| 4 |
Dycom Industries
DY
|
+$17.9M |
| 5 |
COHR
Coherent Inc
COHR
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
+$33.8M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$29.8M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$23.2M |
| 4 |
MaxLinear
MXL
|
+$21.5M |
| 5 |
IDTI
Integrated Device Technology I
IDTI
|
+$21.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.19% |
| 2 | Technology | 24.88% |
| 3 | Industrials | 17.85% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Consumer Staples | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lumentum
LITE
$69.3B
| $27.2M | 1.37% |
480,305
+131,707
| +38% | +$6.32M |
|
27
Medifast
MED
$141M
| $26.2M | 1.32% |
205,206
+95,253
| +87% | +$12.1M |
|
28
MacroGenics
MGNX
$257M
| $25.9M | 1.31% |
1,443,196
+764,646
| +113% | +$13.2M |
|
|
WNS
29
DELISTED
WNS Holdings
WNS
| $25M | 1.26% |
469,627
-108
| -0% | -$5.41K |
|
|
TIER
30
DELISTED
TIER REIT, Inc.
TIER
| $24M | 1.21% |
837,463
-62,677
| -7% | -$1.49M |
|
|
31
Merit Medical Systems
MMSI
$5.32B
| $23.9M | 1.2% |
+386,661
| New | +$21.9M |
|
32
Orthofix Medical
OFIX
$419M
| $23.4M | 1.18% |
414,618
+46,695
| +13% | +$2.62M |
|
|
33
Zumiez
ZUMZ
$339M
| $23.1M | 1.16% |
+928,207
| New | +$22M |
|
34
Laureate Education
LAUR
$5.28B
| $23.1M | 1.16% |
1,541,817
-65,979
| -4% | -$999K |
|
35
Tandem Diabetes Care
TNDM
$1.56B
| $22.5M | 1.13% |
353,708
-100,660
| -22% | -$5.29M |
|
36
Hexcel
HXL
$7.82B
| $22.3M | 1.12% |
322,464
-109,817
| -25% | -$7.38M |
|
|
EVBG
37
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $22.1M | 1.11% |
294,983
-10,399
| -3% | -$679K |
|
38
Euronet Worldwide
EEFT
$2.7B
| $21.8M | 1.1% |
153,178
-160,552
| -51% | -$20M |
|
|
WMGI
39
DELISTED
Wright Medical Group Inc
WMGI
| $21.2M | 1.07% |
675,204
+19,004
| +3% | +$577K |
|
|
TELL
40
DELISTED
Tellurian Inc.
TELL
| $19.9M | 1% |
1,772,717
+1,297,594
| +273% | +$12.2M |
|
41
Stoneridge
SRI
$213M
| $19.8M | 1% |
687,278
-143,923
| -17% | -$3.93M |
|
42
Innovative Industrial Properties
IIPR
$1.72B
| $19.4M | 0.97% |
237,047
-70,078
| -23% | -$4.74M |
|
|
WIRE
43
DELISTED
Encore Wire Corp
WIRE
| $19M | 0.96% |
332,089
+191,807
| +137% | +$10.6M |
|
44
Paylocity
PCTY
$7.98B
| $18.8M | 0.95% |
210,890
-9,132
| -4% | -$710K |
|
|
EFOR
45
Everforth Inc
EFOR
$1.32B
| $18.4M | 0.93% |
290,417
-12,608
| -4% | -$788K |
|
46
Adeia
ADEA
$3.11B
| $18.1M | 0.91% |
2,920,700
+169,805
| +6% | +$998K |
|
47
Digimarc Corp
DMRC
$178M
| $18M | 0.91% |
573,541
-51,549
| -8% | -$1.28M |
|
|
EGIO
48
DELISTED
Edgio, Inc. Common Stock
EGIO
| $17.7M | 0.89% |
137,257
-10,896
| -7% | -$1.27M |
|
|
COHR
49
DELISTED
Coherent Inc
COHR
| $17.6M | 0.88% |
+124,034
| New | +$15.7M |
|
50
Teladoc Health
TDOC
$1.3B
| $16.8M | 0.84% |
301,913
-12,901
| -4% | -$788K |
|
Similar funds
RI
HI
MF
RA
GI
IIM
ACA
MPI
Hood River Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Hood River Capital Management held 125 positions worth $1.99B, up 17% from $1.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Hood River Capital Management's Q1 2019 filing shows 24 new, 23 increased, 53 reduced and 20 closed positions. Its largest new stake was Zumiez: 928,207 shares worth $23.1M. The largest sale was NuVasive, Inc., an estimated $33.8M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
- Hood River Capital Management's largest Q1 2019 buy was Zumiez: 928,207 shares worth $23.1M.
- Hood River Capital Management added most to Sage Therapeutics in Q1 2019, an estimated $30.3M increase.
- Hood River Capital Management's biggest Q1 2019 reduction was Caesars Entertainment, cutting an estimated $20.4M.
- Hood River Capital Management fully exited NuVasive, Inc. in Q1 2019, selling an estimated $33.8M.
- Hood River Capital Management's ten largest holdings make up 24% of its $1.99B portfolio in Q1 2019.
- Hood River Capital Management opened 24 new positions and closed 20 in Q1 2019.
- Hood River Capital Management's portfolio value rose 17% quarter-over-quarter to $1.99B.
Based on Hood River Capital Management's 13F filing for Q1 2019, filed 14 May 2019.